medical insert in patients with osteonecrosis of the femur head
Not Applicable
- Conditions
- Idiopathic femoral head Osteonecrosis.
- Registration Number
- IRCT20180714040468N1
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 17
Inclusion Criteria
Dissatisfaction with surgery
Exclusion Criteria
Failure to perform hip surgery in the past year
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percentage of the Effect of shoe inserts on Pain Reduction and the Prevention of Clinical and Radiographic Progression in Patients with Idiopathic femoral head Osteonecrosis. Timepoint: Every 3 month until one year. Method of measurement: With FICAT and HHS standard forms.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways does silicone therapy target in idiopathic osteonecrosis of the femoral head (IRCT20180714040468N1)?
How does silicone therapy compare to bisphosphonates or core decompression in idiopathic osteonecrosis of the femoral head?
Which biomarkers correlate with radiological improvement in silicone therapy for idiopathic osteonecrosis of the femoral head?
What adverse events are associated with silicone therapy in idiopathic osteonecrosis of the femoral head trials?
Are there combination therapies with silicone for idiopathic osteonecrosis of the femoral head, and how do they compare to monotherapy?